Compare TOWN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | EVO |
|---|---|---|
| Founded | 1998 | 1993 |
| Country | United States | Germany |
| Employees | 1251 | 4766 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | TOWN | EVO |
|---|---|---|
| Price | $32.93 | $2.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 359.8K | 123.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.63 | N/A |
| Revenue Next Year | $5.18 | $7.13 |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.43 | $2.40 |
| 52 Week High | $37.86 | $4.80 |
| Indicator | TOWN | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 34.33 | 22.77 |
| Support Level | $32.22 | N/A |
| Resistance Level | $34.28 | $3.78 |
| Average True Range (ATR) | 0.91 | 0.10 |
| MACD | -0.19 | -0.10 |
| Stochastic Oscillator | 19.38 | 2.12 |
Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.